One-year patient and graft survivals were 62% and 54% versus 86% and 79%, respectively, for the NHBD and HBD groups (P = .107 and P = .003).

• 在NHBD组和HBD组中，患者的一年存活率分别为62%25和86%25（P=.；107），而移植肝的一年存活率分别为54%25和79%25（P=